September 10, 2019

• Department of Commerce
  Collaborative Science, Technology, and Applied Research (CSTAR) Program

• Naval Research Laboratory
  NRL Long Range Broad Agency Announcement (BAA) for Basic and Applied Research
• Office of Naval Research
  Department of Defense Explosives Ordnance Disposal (EOD) FY20 Science & Technology Program Broad Agency Announcement (BAA) Development of Advanced Technologies for Diagnostic Sensors and Neutralization of Buried & Surface Munitions in Land Environments

• Headquarters
  MINORITY EDUCATION, WORKFORCE, AND TRAINING PROGRAM

• National Park Service
  K-12 Students’ Stories and Perspectives Curriculum Development
• Fish and Wildlife Service
  Youth Engagement, Education, and Employment Programs

• Environmental Protection Agency
  Manage Local Government Compliance Assistance Center

• National Institutes of Health
  Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed)
• National Institutes of Health
  Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed)
• National Institutes of Health
  Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed)
• National Institutes of Health
  Trans-Agency Blood-Brain Interface Program (R61/R33 – Clinical Trials Not Allowed)
• Centers for Disease Control and Prevention – ERA
  Natural Experiments of the Impact of Population-targeted Policies to Prevent Type 2 Diabetes and Diabetes Complications
• National Institutes of Health
  The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
• Centers for Disease Control and Prevention – ERA
  Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome to Improve Service and Outcome
• Health Resources and Services Administration
  AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)
• National Institutes of Health
  Notice of Intent to Publish Reissuance of RFA-OD-19-019 “Tobacco Regulatory Science (R01 Clinical Trial Optional)”
• National Institutes of Health
  Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
• National Institutes of Health
  Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
• National Institutes of Health
  Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)
• National Institutes of Health
  Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Clinical Research Centers (U01 Clinical Trial Optional)
• National Institutes of Health
  Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Scientific and Data Coordinating Center (U24 Clinical Trial Optional)

Back to Top

National Aeronautics and Space Administration (NASA)

Back to Top

National Science Foundation (NSF)

Back to Top

Small Business Association (SBA)

Back to Top